학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 145건 | 목록 1~10
Academic Journal
Patil SU; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Dougan M; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston.
Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE
Academic Journal
Aney KJ; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, Massachusetts; Health Sciences & Technology Program, Harvard-MIT, Boston, Massachusetts; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Jeong WJ; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Vallejo AF; University of Southampton, Southampton, United Kingdom.; Burdziak C; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Chen E; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang A; Harvard University, Cambridge, Massachusetts.; Koak P; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wise K; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia.; Jensen K; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia; Australian Genome Research Facility, Melbourne, Victoria, Australia.; Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York; Howard Hughes Medical Institute, Chevy Chase, Maryland.; Dougan SK; Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Martelotto L; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia. Electronic address: luciano.martelotto@adelaide.edu.au.; Nissim S; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, Massachusetts; Health Sciences & Technology Program, Harvard-MIT, Boston, Massachusetts; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts; Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: snissim@bwh.harvard.edu.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Academic Journal
Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bauer TW; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Patel A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang J; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.; Stucky CH; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Bekaii-Saab TS; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Elias R; Hartford Healthcare Cancer Institute, Hartford, Connecticut.; Merchant N; Department of Surgery, University of Miami, Miami, Florida.; Slingluff CL Jr; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Huang YH; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Zhu C; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Kondo Y; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Anderson AC; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Gandhi A; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Russell A; Rosenstiel Basic Medical Sciences Research Center, Brandeis University, 415 South Street, Waltham, 02454, Massachusetts, USA.; Dougan SK; Whitehead Institute, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USA.; Petersen BS; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.; Melum E; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Division of Cancer Medicine, Norwegian PSC Research Center, Surgery and Transplantation, Oslo University Hospital, Oslo 0424, Norway.; Pertel T; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Clayton KL; Department of Immunology, University of Toronto, Toronto, Ontario M5S1A8, Canada.; Raab M; Department of Pathology, Cell Signalling Section, University of Cambridge, Cambridge CB2 1QP, UK.; Chen Q; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.; Beauchemin N; Goodman Cancer Research Centre, McGill University, Montreal H3G 1Y6, Canada.; Yazaki PJ; Beckman Institute, City of Hope, Duarte, 91010, California, USA.; Pyzik M; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Ostrowski MA; Department of Immunology, University of Toronto, Toronto, Ontario M5S1A8, Canada.; Keenan Research Centre of St. Michael's Hospital, Toronto, Ontario M5S1A8, Canada.; Glickman JN; GI Pathology, Miraca Life Sciences, Newton, 02464, Massachusetts, USA.; Rudd CE; Department of Pathology, Cell Signalling Section, University of Cambridge, Cambridge CB2 1QP, UK.; Ploegh HL; Whitehead Institute, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USA.; Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.; Petsko GA; Rosenstiel Basic Medical Sciences Research Center, Brandeis University, 415 South Street, Waltham, 02454, Massachusetts, USA.; Kuchroo VK; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Blumberg RS; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA. rblumberg@partners.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ali LR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Horick N; Massachusetts General Hospital, Boston, Massachusetts, USA.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Metayer KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Murray S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Goessling W; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Mouw K; Harvard Medical School, Boston, Massachusetts, USA.; Reardon B; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Zerillo JA; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Clark JW; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Parikh A; Massachusetts General Hospital, Boston, Massachusetts, USA.; Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Schlechter B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Kumar S; Naveris, Inc, Waltham, Massachusetts, USA.; Del Vecchio Fitz C; Naveris, Inc, Waltham, Massachusetts, USA.; Kuperwasser C; Naveris, Inc, Waltham, Massachusetts, USA.; Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Coveler AL; University of Washington School of Medicine, Seattle, Washington, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Welsh EL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Pfaff K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Kureshi R; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bello E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Kureshi CTS; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Walsh MJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Lippert V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hoffman MT; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dougan M; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Longmire T; Bristol Myers Squibb, Cambridge, MA, USA.; Wichroski M; Bristol Myers Squibb, Cambridge, MA, USA.; Dougan SK; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Academic Journal
Qiang L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Castillo JI; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kageler L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Temesgen A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Bello E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Uribe GA; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Yang A; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Aguirre AJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Raghavan S; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Pelletier M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Cremasco V; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts. Electronic address: stephanie_dougan@dfci.harvard.edu.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Academic Journal
Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mhgkatz@mdanderson.org.; Petroni GR; Division of Translational Research and Applied Statistics, Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia, USA.; Bauer T; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA.; Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Stucky CC; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Bekaii-Saab TS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clin, Phoenix, Arizona, USA.; Elias R; Hartford HealthCare Cancer Institute, Plainville, Connecticut, USA.; Merchant N; Department of Surgery, University of Miami, Coral Gables, Florida, USA.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Rodig S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Pfaff K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Nowak JA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Varadhachary GR; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Slingluff CL; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia, USA.; Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Walsh MJ; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Harvard Program in Virology, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Kureshi CT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Kureshi R; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Knipe DM; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology, Harvard Medical School, Boston, MA, USA.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Dougan SK
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어